Data from a recent multi-center pilot study utilizing Axiom Worldwide’s DRX9000 Reveals a Dramatic Success Rate of 88.9%!
The clinical results of an IRB-approved prospective, multi-center, phase II, non-randomized pilot study utilizing the DRX9000 was presented at the annual New York State Society of Anesthesiologists PGA meeting in New York City December 7-11, 2007. The study, authored by Dr. John Leslie